Axsome Therapeutics, Inc. logo

Axsome Therapeutics, Inc. (AXSM)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS)
$
157. 14
-4.65
-2.8741%
$
8.23B Market Cap
- P/E Ratio
- Div Yield
873,100 Volume
-4.27 Eps
$ 161.79
Previous Close
Add Transaction
Day Range
156.09 160.43
Year Range
123.5 260.19
Want to track AXSM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Axsome Therapeutics, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
1,085 $111,013.03 $169,997.8 $58,984.77 53.13%
JCB
John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH
63,551 $7.63M $10.28M $2.66M 34.81%
Ameriflex Group Inc.
Ameriflex Group Inc. Ameriflex Group Inc.
887 $190,519.87 $143,507.73 -$47,012.14 -24.68%
Kilter Group LLC
Kilter Group LLC Kilter Group LLC
6 $1,394.17 $970.74 -$423.43 -30.37%
Corinne Lafaurie-Konter
Corinne Lafaurie-Konter 111 Capital
1,839 $450,132 $287,693.16 -$162,438.84 -36.09%
Nicole Reese
Nicole Reese WPG Advisers LLC
76 $10,644.42 $12,296.04 $1,651.62 15.52%
Birch Financial Group LLC
Birch Financial Group LLC Birch Financial Group LLC
1,675 $283,124.35 $267,179.25 -$15,945.1 -5.63%
Occam Crest Management LP
Occam Crest Management LP Occam Crest Management LP
29,800 $3.74M $4.71M $972,770 26%